MEDICINSKI GLASNIK , 10(2), 203-210
Cagrilintide works at microgram-level potency (2.4 mg maintenance), while retatrutide requires milligram-level doses up to 12 mg
Saxena N, Beraldi E, Fazli L, Somasekharan SP, Adomat H, Zhang F, et al
Some studies have reported no significant differences in IGF-1 levels or side effects following interventions such as lycopene supplementation or calorie restriction, suggesting a lack of direct effect in certain cases
These results indicate that the affinity sorting system can increase gene modification to a larger extent and allow the observation of more profound gene biological functions
In addition, during systemic IGF-1 therapy, four cases of benign tumors and one case of malignant tumor have been reported as treatment-emergent adverse events (TEAEs)